Detalhe da pesquisa
1.
Disseminated cancer cells in breast cancer: Mechanism of dissemination and dormancy and emerging insights on therapeutic opportunities.
Semin Cancer Biol
; 78: 78-89, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33626407
2.
Th1 cytokine interferon gamma improves response in HER2 breast cancer by modulating the ubiquitin proteasomal pathway.
Mol Ther
; 29(4): 1541-1556, 2021 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33412308
3.
Intratumoral delivery of dendritic cells plus anti-HER2 therapy triggers both robust systemic antitumor immunity and complete regression in HER2 mammary carcinoma.
J Immunother Cancer
; 10(6)2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35710296
4.
Differentiation and Regulation of TH Cells: A Balancing Act for Cancer Immunotherapy.
Front Immunol
; 12: 669474, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34012451
5.
Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response.
Front Immunol
; 10: 1939, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31475002